KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Accounts Payables (2016 - 2025)

Pfizer (PFE) has disclosed Accounts Payables for 17 consecutive years, with $5.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 6.98% to $5.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.2 billion, a 6.98% decrease, with the full-year FY2025 number at $5.2 billion, down 6.98% from a year prior.
  • Accounts Payables was $5.2 billion for Q4 2025 at Pfizer, up from $5.0 billion in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $6.8 billion in Q4 2022 to a low of $4.1 billion in Q2 2021.
  • A 5-year average of $5.5 billion and a median of $5.4 billion in 2022 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: surged 43.47% in 2022, then decreased 16.05% in 2024.
  • Pfizer's Accounts Payables stood at $5.6 billion in 2021, then increased by 22.07% to $6.8 billion in 2022, then dropped by 1.45% to $6.7 billion in 2023, then fell by 16.05% to $5.6 billion in 2024, then dropped by 6.98% to $5.2 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Accounts Payables are $5.2 billion (Q4 2025), $5.0 billion (Q3 2025), and $5.2 billion (Q2 2025).